Quantum-Si to Present at the 42nd Annual Cowen Health Care Conference
GUILFORD, Conn.–(BUSINESS WIRE)– February 18, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing single molecule protein sequencing, today announced that it will be participating virtually in the 42nd Annual Cowen Health Care Conference.
Quantum-Si’s management is scheduled to present virtually on Tuesday, March 8, 2022 at 2:10 pm ET.
A live webcast of the event will be available in the Events & Presentations section of the Quantum-Si investor website. A replay will be available on the Company’s website following the event.
About Quantum-Si Incorporated
Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single molecule next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantumsi.supremeclients.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220218005326/en/
Investors
Juan Avendano
Mike Cavanaugh
[email protected]
Media
Jon Yu
[email protected]
Source: Quantum-Si Incorporated